Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1978 2
1981 1
1982 3
1983 4
1984 4
1986 1
1987 1
1989 5
1991 1
1992 1
1995 3
1996 3
1998 1
2002 2
2003 1
2004 1
2005 1
2006 1
2007 1
2008 4
2009 2
2010 5
2011 4
2012 5
2013 4
2014 5
2015 5
2016 10
2017 6
2018 3
2019 1
2020 4
2021 10
2022 8
2023 4
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Results by year

Filters applied: . Clear all
Page 1
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
CRASH-2 trial collaborators; Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejía-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S. CRASH-2 trial collaborators, et al. Lancet. 2010 Jul 3;376(9734):23-32. doi: 10.1016/S0140-6736(10)60835-5. Epub 2010 Jun 14. Lancet. 2010. PMID: 20554319 Clinical Trial.
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial.
CRASH-2 collaborators; Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T. CRASH-2 collaborators, et al. Lancet. 2011 Mar 26;377(9771):1096-101, 1101.e1-2. doi: 10.1016/S0140-6736(11)60278-X. Lancet. 2011. PMID: 21439633 Clinical Trial.
Focal Segmental Glomerulosclerosis: Assessing the Risk of Relapse.
Troyanov S, Jauhal A, Reich HN, Hladunewich MA, Cattran DC; Toronto Glomerulonephritis Registry Group. Troyanov S, et al. Kidney Int Rep. 2023 Sep 9;8(11):2403-2415. doi: 10.1016/j.ekir.2023.08.035. eCollection 2023 Nov. Kidney Int Rep. 2023. PMID: 38025232 Free PMC article.
NIEHS/FDA CLARITY-BPA research program update.
Heindel JJ, Newbold RR, Bucher JR, Camacho L, Delclos KB, Lewis SM, Vanlandingham M, Churchwell MI, Twaddle NC, McLellen M, Chidambaram M, Bryant M, Woodling K, Gamboa da Costa G, Ferguson SA, Flaws J, Howard PC, Walker NJ, Zoeller RT, Fostel J, Favaro C, Schug TT. Heindel JJ, et al. Among authors: chidambaram m. Reprod Toxicol. 2015 Dec;58:33-44. doi: 10.1016/j.reprotox.2015.07.075. Epub 2015 Jul 29. Reprod Toxicol. 2015. PMID: 26232693 Free PMC article. Review.
Algae to Economically Viable Low-Carbon-Footprint Oil.
Bhujade R, Chidambaram M, Kumar A, Sapre A. Bhujade R, et al. Among authors: chidambaram m. Annu Rev Chem Biomol Eng. 2017 Jun 7;8:335-357. doi: 10.1146/annurev-chembioeng-060816-101630. Annu Rev Chem Biomol Eng. 2017. PMID: 28592173 Review.
A Rare Adverse Effect Following Prolonged Linezolid Therapy.
Meera M, Kanna N, Chidambaram M. Meera M, et al. Among authors: chidambaram m. Indian J Pediatr. 2023 Jun;90(6):618. doi: 10.1007/s12098-023-04535-7. Epub 2023 Mar 15. Indian J Pediatr. 2023. PMID: 36918472 No abstract available.
108 results